Medical Weight Loss for Bountiful, Utah Residents
Bountiful, Utah residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Bountiful through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Bountiful Residents Choose New Hope Weight Loss
New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, California that has treated over 5,400 patients since 2020. We serve Bountiful, Utah through telehealth at some of the most transparent prices anywhere, semaglutide from $166/month and tirzepatide from $233/month · just $7.70/day. No insurance battles, no hidden fees. Care is overseen by Dr. Anjmun Sharma, M.D.
Medical weight loss for Bountiful is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.
Bountiful is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout downtown Bountiful and the southern Davis County area north of Salt Lake City. Compounded semaglutide and tirzepatide ship directly to your door in Utah, and a licensed physician reviews every plan before anything is prescribed.
Like much of Utah, many people in Bountiful want a physician-supervised weight-loss option without local waitlists or unclear pricing. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Bountiful patients.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Bountiful patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Bountiful
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Bountiful address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Bountiful
How do I get treatment from Bountiful?
As a Bountiful, Utah patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Bountiful?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Bountiful in cold-pack packaging, no lines and no drive.
How much does it cost for Bountiful patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Bountiful do you serve?
We serve patients from across Bountiful by telehealth, including downtown Bountiful and the southern Davis County area north of Salt Lake City.
Is my health information private as a Bountiful patient?
Yes. Your intake, video visits, and records are handled under HIPAA safeguards, and medication arrives in discreet packaging. Bountiful patients get the same confidentiality as any telehealth patient.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Bountiful, Utah by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.